This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Baxalta Gmbh, Children's Medical Center Corporation, Takeda Pharmaceutical Company Limited. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 153 
2 out of 1,077 
1 out of 1,232 
Years Active: 2019-2021
Title: Anil Kumar Chauhan: Innovator in Thrombolytic Therapy
Introduction
Anil Kumar Chauhan is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of thrombolytic therapies. With a total of 2 patents, his work focuses on innovative solutions for treating thrombus-related disorders.
Latest Patents
Chauhan's latest patents include compositions that contain ADAMTS13, which have demonstrated thrombolytic activity. This invention relates to a pharmaceutical composition that comprises ADAMTS13 and methods for treating or preventing disorders associated with the formation and presence of thrombus. The invention also outlines methods for disintegrating thrombus in patients who require such treatment. Furthermore, it emphasizes the use of a pharmaceutically effective amount of ADAMTS13 for preparing compositions aimed at treating or preventing thrombus-related disorders.
Career Highlights
Throughout his career, Anil Kumar Chauhan has worked with prominent organizations such as Baxalta GmbH and Children's Medical Center Corporation. His experience in these companies has allowed him to refine his expertise in pharmaceutical innovations and contribute to significant advancements in medical therapies.
Collaborations
Chauhan has collaborated with esteemed colleagues, including Denisa D Wagner and Friedrich Scheiflinger. These partnerships have further enriched his research and development efforts in the field of thrombolytic therapy.
Conclusion
Anil Kumar Chauhan's contributions to thrombolytic therapy through his innovative patents and collaborations highlight his role as a key figure in the pharmaceutical industry. His work continues to pave the way for advancements in treating thrombus-related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile